1217 related articles for article (PubMed ID: 19386450)
1. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
3. The effect of clomiphene citrate on osteoporosis in ovariectomized rats.
Uyar Y; Koltan SO; Pögün S; Vatansever S; Caglar H
Arch Gynecol Obstet; 2008 Aug; 278(2):107-14. PubMed ID: 18193254
[TBL] [Abstract][Full Text] [Related]
4. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW
J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats.
Gradosova I; Zivna H; Palicka V; Hubena S; Svejkovska K; Zivny P
Eur J Pharmacol; 2012 Mar; 679(1-3):144-50. PubMed ID: 22306245
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.
Naves-Díaz M; Carrillo-López N; Rodríguez-Rodríguez A; Braga S; Fernández-Coto T; Lopez-Novoa JM; López-Hernández F; Cannata-Andía JB
Menopause; 2010 Jul; 17(4):766-71. PubMed ID: 20386345
[TBL] [Abstract][Full Text] [Related]
8. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
9. [One year observation on effects of estrogen, tamoxifen combined with or without fluoride on preventing bone loss in ovariectomized rats].
Liu H; Peng H; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):82-5. PubMed ID: 11953070
[TBL] [Abstract][Full Text] [Related]
10. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene.
Helvering LM; Liu R; Kulkarni NH; Wei T; Chen P; Huang S; Lawrence F; Halladay DL; Miles RR; Ambrose EM; Sato M; Ma YL; Frolik CA; Dow ER; Bryant HU; Onyia JE
Mol Pharmacol; 2005 Nov; 68(5):1225-38. PubMed ID: 16079270
[TBL] [Abstract][Full Text] [Related]
12. Flaxseed does not antagonize the effect of ultra-low-dose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats.
Sacco SM; Jiang JM; Reza-Lopez S; Ma DW; Thompson LU; Ward WE
J Toxicol Environ Health A; 2009; 72(20):1209-16. PubMed ID: 20077189
[TBL] [Abstract][Full Text] [Related]
13. A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats.
Ammann P; Bourrin S; Brunner F; Meyer JM; Clément-Lacroix P; Baron R; Gaillard M; Rizzoli R
Bone; 2004 Jul; 35(1):153-61. PubMed ID: 15207751
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
15. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
[TBL] [Abstract][Full Text] [Related]
16. The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats.
Osterman T; Laurén L; Kuurtamo P; Hannuniemi R; Isaksson P; Kippo K; Peng Z; Väänänen HK; Sellman R
J Pharmacol Exp Ther; 1998 Jan; 284(1):312-6. PubMed ID: 9435193
[TBL] [Abstract][Full Text] [Related]
17. Effect of administration of alendronate sodium and retinol on the mechanical properties of the femur in ovariectomized rats.
Sliwiński L; Janiec W; Pytlik M; Folwarczna J; Kaczmarczyk-Sedlak I; Pytlik W; Cegieła U; Nowińska B
Pol J Pharmacol; 2004; 56(6):817-24. PubMed ID: 15662095
[TBL] [Abstract][Full Text] [Related]
18. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
[TBL] [Abstract][Full Text] [Related]
19. Biomechanical and histological outcome of combined raloxifene-estrogen therapy on skeletal and reproductive tissues.
Tasci A; Bilgili H; Altunay H; Gecit MR; Keskin D
Eur J Pharmacol; 2010 Feb; 627(1-3):354-61. PubMed ID: 19903467
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]